Immune checkpoint: The novel target for antitumor therapy

Inhibitory checkpoint molecules include programmed cell death-1 (PD-1), programmed cell death ligand-1 (PD-L1), cytotoxic T lymphocyte antigen-4 (CTLA-4), human endogenous retrovirus-H Long terminal repeat-associating 2 (HHLA2), B7 homolog 4 protein (B7-H4), T cell membrane protein-3 (TIM-3) and Lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xianghu, Liu, Guohong, Li, Yirong, Pan, Yunbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859424/
https://www.ncbi.nlm.nih.gov/pubmed/33569511
http://dx.doi.org/10.1016/j.gendis.2019.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859424/
https://www.ncbi.nlm.nih.gov/pubmed/33569511
http://dx.doi.org/10.1016/j.gendis.2019.12.004

Ejemplares similares